Efficacy and Safety of ior® EPOCIM for Chemotherapy- or Radiotherapy-Induced Anemia in Pediatric Cancer Patients
INTRODUCTION:Recombinant human erythropoietin (RHuEPO) isan erythropoiesis stimulating agent (ESA) used to treat anemia in pa-tients with total or relative erythropoietin deficit. In cancer patients, it isadministered to optimize hemoglobin (Hb) levels, correct anemia andreduce the need for transfus...
Kaydedildi:
| Yayımlandı: | MEDICC Review |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medical Education Cooperation with Cuba
2010
|
| Konular: | |
| Online Erişim: | https://www.redalyc.org/articulo.oa?id=437542103007 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|